Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication

Tobias Moll(University of Sheffield), Johnathan Cooper‐Knock(University of Sheffield)

Life Science Alliance

October 14, 2022

10.26508/lsa.202201449

Cited by 4

Related Papers

Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy

|Acta Neuropathologica|2015|170

Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity

|Cell Systems|2022|37

Atypical<scp>TDP</scp>‐43 protein expression in an<scp>ALS</scp>pedigree carrying a p.<scp>Y374X</scp>truncation mutation in<i>TARDBP</i>

|Brain Pathology|2022|8

Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity

|medRxiv|2021|7